Quantitative immunohistochemistry in lung cancer: clinical perspective

被引：6
|
作者：
Szutowicz, Ewa [1 ]
Dziadziuszko, Rafal [1 ]
机构：
[1] Med Acad Gdansk, Dept Radiotherapy & Oncol, PL-80211 Gdansk, Poland
来源：
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA | 2010年 / 48卷 / 01期
关键词：
lung cancer; immunohistochemistry; clinical trials; protein expression; FACTOR RECEPTOR EXPRESSION; TRIAL BIOLOGIC PROGRAM; ADJUVANT CHEMOTHERAPY; PREDICT BENEFIT; CELL; SURVIVAL; GEFITINIB; CISPLATIN; ERLOTINIB; ERCC1;
D O I：
10.2478/v10042-010-0014-2
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Quantitative immunohistochemistry remains an important tool in translational lung cancer research with hopes to improve patient outcomes and avoid unnecessary therapies. Present review is aimed to summarize the use of immunohistochemical markers for improved prognostic information and prediction of treatment benefit. Several of these markers are currently explored in phase II - III clinical studies to individualize the treatment of lung cancer.
引用
收藏
页码：7 / 11
页数：5
相关论文
共 50 条
  • [1] Rediscovering immunohistochemistry in lung cancer
    La Salvia, Anna
    Meyer, May-Lucie
    Hirsch, Fred R.
    Kerr, Keith M.
    Landi, Lorenza
    Tsao, Ming-Sound
    Cappuzzo, Federico
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 200
  • [2] Immunohistochemistry of Lung Cancer Biomarkers
    Beasley, Mary Beth
    ADVANCES IN ANATOMIC PATHOLOGY, 2024, 31 (05) : 333 - 343
  • [3] Biological markers in lung cancer: A clinician's perspective
    Tufman, Amanda
    Huber, Rudolph Maria
    CANCER BIOMARKERS, 2010, 6 (3-4) : 123 - 135
  • [4] Role of immunohistochemistry in the diagnosis of lung cancer
    Capelozzi, Vera Luiza
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2009, 35 (04) : 375 - 382
  • [5] IMPORTANCE OF IMMUNOHISTOCHEMISTRY (IHC) ON THE DIAGNOSIS OF LUNG CANCER
    Charalambous, Haris
    Decatris, Marios P.
    Katodritis, Nikos
    Vomvas, Demetrios
    Charalambous, Charis
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1532 - S1533
  • [6] Is Immunohistochemistry Always Required to Diagnose Lung Cancer?
    Rossi, Giulio
    Tiseo, Marcello
    Cavazza, Alberto
    Colby, Thomas V.
    ADVANCES IN ANATOMIC PATHOLOGY, 2013, 20 (05) : 327 - 333
  • [7] Any Place for Immunohistochemistry within the Predictive Biomarkers of Treatment in Lung Cancer Patients?
    Hofman, Veronique
    Lassalle, Sandra
    Bence, Coraline
    Long-Mira, Elodie
    Nahon-Esteve, Sacha
    Heeke, Simon
    Lespinet-Fabre, Virginie
    Butori, Catherine
    Ilie, Marius
    Hofman, Paul
    CANCERS, 2018, 10 (03)
  • [8] Biomarkers in the Lung Cancer Diagnosis: A Clinical Perspective
    Li, X.
    Asmitananda, T.
    Gao, L.
    Gai, D.
    Song, Z.
    Zhang, Y.
    Ren, H.
    Yang, T.
    Chen, T.
    Chen, M.
    NEOPLASMA, 2012, 59 (05) : 500 - 507
  • [9] Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer
    Yatabe, Yasushi
    Dacic, Sanja
    Borczuk, Alain C.
    Warth, Arne
    Russell, Prudence A.
    Lantuejoul, Sylvie
    Beasley, Mary Beth
    Thunnissen, Erik
    Pelosi, Giuseppe
    Rekhtman, Natasha
    Bubendorf, Lukas
    Mino-Kenudson, Mari
    Yoshida, Akihiko
    Geisinger, Kim R.
    Noguchi, Masayuki
    Chirieac, Lucian R.
    Bolting, Johan
    Chung, Jin-Haeng
    Chou, Teh-Ying
    Chen, Gang
    Poleri, Claudia
    Lopez-Rios, Fernando
    Papotti, Mauro
    Sholl, Lynette M.
    Roden, Anja C.
    Travis, William D.
    Hirsch, Fred R.
    Kerr, Keith M.
    Tsao, Ming-Sound
    Nicholson, Andrew G.
    Wistuba, Ignacio
    Moreira, Andre L.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (03) : 377 - 407
  • [10] Immunohistochemistry-based predictive biomarkers for lung cancer
    Schildhaus, Hans-Ulrich
    PATHOLOGE, 2020, 41 (01): : 21 - 31
12345